News | Orthopedic Imaging | January 11, 2018

Hip Steroid Injections Associated With Bone Changes

A new study indicates that those who receive steroid injections in the hip have higher incidence of bone death and collapse 

Hip Steroid Injections Associated with Bone Changes

58-year-old woman with left hip pain. X-ray from one month prior to the steroid/anesthetic injection demonstrates moderate joint space narrowing (arrows) and bony proliferation (arrowheads).

January 11, 2018 – Osteoarthritis patients who received a steroid injection in the hip had a significantly greater incidence of bone death and collapse compared with control groups, according to new research presented at the annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

Receiving an injection of a steroid and anesthetic is a common treatment for patients who are experiencing pain and inflammation in a joint, such as the hip, knee or shoulder.

"Changes due to osteoarthritis, such as narrowing in the space between joints and the development of bony proliferations, typically develop slowly over time," said Connie Y. Chang, M.D., radiologist at Massachusetts General Hospital and assistant professor of radiology at Harvard Medical School in Boston. "When reading follow-up radiographs of patients who had received a hip injection, we noticed changes had developed rapidly in some patients."

To determine whether arthritis worsened in patients following a hip steroid/anesthetic injection, Chang and a team of radiologists specializing in musculoskeletal diagnostic imaging and intervention, including hip injections, conducted a study involving 102 patients (age range 19-92, including 62 women) who received X-ray images of the treated hip at the time of the injection and during a follow-up three to nine months later.

Two musculoskeletal radiologists independently reviewed the X-ray images of the patients who received the injections and those of two control groups matched to demographics and follow-up imaging duration. The control groups consisted of 102 patients who had hip X-rays without steroid/anesthetic injection and 44 patients who underwent imaging and a steroid/anesthetic injection in the shoulder.

The radiologists reported new osteonecrosis in 22-24 percent of hip injection patients, compared to 5-9 percent in the hip control group and 5 percent in the shoulder injection control group. They observed bone collapse in the head of the femur bone, located at the top of the femur at the articulation with the pelvic bone, in 15-17 percent of hip injection patients, versus 4 percent of hip control patients and 2 percent of shoulder control patients.

Hip injection patients also showed increased imaging findings of osteoarthritis compared to the control groups, but the differences were not statistically significant.

Chang noted that patients receiving hip injections have symptoms of hip pain severe enough to require the injection and may be prone to faster progression of bony changes compared to the control groups. These considerations may be important, as some orthopedists are requesting higher steroid doses and injections in younger patients.

"We need to look at what's going on with the steroid/anesthetic injectate and osteoarthritis patients to determine what's causing the changes that occur in some patients," Chang said. "However, we don't want to deter patients from getting an injection. These results are enough to warrant an investigation, but not enough to cancel a procedure."

Co-authors are F. Joseph Simeone, M.D., Joao Rafael T. Vicentini, M.D., and Susan V. Kattapuram, M.D.

For more information: www.rsna.org  

Related Content

Key RSNA 2017 Study Presentations, Trends and Video

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
First Patient Enrolled in World's Largest Brain Cancer Clinical Trial
News | Radiation Therapy | August 15, 2019
Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive...
Efficacy of Isoray's Cesium Blu Showcased in Recent Studies
News | Brachytherapy Systems | August 14, 2019
August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica
Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Videos | Radiographic Fluoroscopy (RF) | August 09, 2019
Shimadzu displayed the FluoroSpeed X1 conventional radiographic fluoroscopy (RF) system at the Association for Medica
Shimadzu Medical Systems Receives FDA 510(k) for FluoroSpeed X1 RF System
Technology | Radiographic Fluoroscopy (RF) | August 09, 2019
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corp., announced they have received U.S. Food and Drug...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Rise in Early Onset Colorectal Cancer Not Aligned With Screening Trends
News | Colonoscopy Systems | August 06, 2019
A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in...